Anne Marciniak MPhil, MSc, PhD, MD

Anne Marciniak is a researcher at Brunel University and an independent strategic consultant in Market Access. She has 20-year experience in Market Access and Health Economics in the pharmaceutical industry, including Pfizer, Amgen, Daiichi-Sankyo, and most recently Allergan.
Dr. Marciniak led the Market Access strategy of multiple compounds in the European environment focussing on meeting the needs of payers at national, regional and local levels. She has hands-on experience in establishing strategies and leading their cross-functional execution, integrating all elements of product value clinical and safety profile, health economics and price.
Anne led payer and HTA consultations and developed the principle and implementation of patients’ engagement into access strategies. She believes that through engagement of all partners involved in the delivery of health care including payers the best value will be achieved for patients and citizens ultimately financing care. She is a physician by training with qualification in Health Economics and Epidemiology.